- Home
- ALT vs CRNC Comparison
ALT vs CRNC Comparison
Compare ALT & CRNC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ALT | CRNC |
|---|---|---|
| Founded | 1997 | 2020 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 421.5M | 479.9M |
| IPO Year | 2005 | 2019 |
Fundamental Metrics
Financial Performance| Metric | ALT | CRNC |
|---|---|---|
| Price | $2.99 | $8.15 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 6 | 4 |
| Target Price | ★ $17.67 | $10.25 |
| AVG Volume (30 Days) | ★ 3.3M | 690.8K |
| Earning Date | 05-08-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 25.37 | ★ 96.95 |
| EPS | N/A | ★ N/A |
| Revenue | $41,000.00 | ★ $251,781,000.00 |
| Revenue This Year | N/A | $27.18 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 105.00 | N/A |
| 52 Week Low | $2.56 | $5.85 |
| 52 Week High | $6.44 | $13.74 |
Technical Indicators
Market Signals| Indicator | ALT | CRNC |
|---|---|---|
| Relative Strength Index (RSI) | 54.11 | 35.74 |
| Support Level | $2.87 | $7.61 |
| Resistance Level | $3.09 | $9.19 |
| Average True Range (ATR) | 0.16 | 0.62 |
| MACD | -0.00 | -0.17 |
| Stochastic Oscillator | 41.07 | 10.50 |
Price Performance
Historical ComparisonAbout ALT Altimmune Inc.
Altimmune Inc is a late clinical-stage biopharmaceutical company developing therapies for patients with serious liver diseases. The Company's key candidate, pemvidutide, is a dual-action therapy targeting both glucagon and GLP-1 receptors in a balanced 1:1 ratio in development for the treatment of metabolic dysfunction-associated steatohepatitis (MASH), alcohol use disorder (AUD), and alcohol-associated liver disease (ALD). The company also plans to pursue additional indications for pemvidutide that leverage the differentiated clinical profile of pemvidutide.
About CRNC Cerence Inc.
Cerence Inc is a United States-based software company. It is involved in developing mobility-based solutions for drivers and their cars. The customers include all automobile original equipment manufacturers, or OEMs, or their tier 1 suppliers. The company's revenue is generated by selling software licenses and cloud-connected services. Geographically, it derives a majority of its revenue from the United States and also has a presence in Other Americas; Germany; Other Europe, the Middle East, Africa; Japan, and Other Asia-Pacific.